Clinical Trials for MimiVax

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: MimiVax

Clinical Trials (1)

NCT05163080
SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)
PHASE2Active, not recruiting
247 participants
Started: Nov 18, 2021 · Completed: Aug 18, 2024
1 condition3 sponsors11 locations